R. Wiewrodt (Philadelphia, United States Of America), P. Zatloukal (Praha, Czech Republic)
Expandable metal stent insertion under local anaesthesia for malignant large airway obstruction: 10 years' experience
P. A. Stockton, L. M. Lukehurst, C. R. K. Hind, M. J. Ledson, M. J. Walshaw (Liverpool, United Kingdom)
|  |
Imaging of malignant pleural mesothelioma with fluordeoxyglucose positron emission tomography (FDG-PET)
A. Gröschel, D. Hellwig, K. Rentz, C. M. Kirsch, D. Ukena, G. W. Sybrecht (Homburg, Germany)
| |
Malignant pleural mesothelioma in our material: evaluation by EORTC prognostic scoring system
J. Stanic, Z. Eri, M. Drvenica, M. Antonic, N. Šolajic (Sremska Kamenica, Yugoslavia)
| |
Erradication of intraperitoneal and distant tumour by adenovirus-mediated interferon-beta gene therapy due to induction of systemic immunity
R. Wiewrodt, M. Odaka, D. H. Sterman, Y. Zhang, K. Amin, G. P. Gao, J. M. Wilson, L. R. Kaiser, S. M. Albelda (Philadelphia, United States Of America)
| |
Histone deacetylase inhibition significantly augments human mesothelioma cellular response to chemotherapeutic agents
M. K. Ozveran, X. X. Cao, I. Mohuiddin, W. R. Smythe (Houston, United States Of America)
| |
Diagnostic utility of CYFRA 21-1 and carcinoembryonic antigen as a tumour markers in malignant pleural effusions
D. Kavkova, E. Varmusova, I. Tudik, J. Mocak, B. Balla, M. Berezova (Poprad-Kvetnica, Bratislava, Slovakia)
| |
Diagnostic value of pleural fluid/serum ratio of beta human chorionic gonadotropin in malignant pleural effusions
A. Zamani, T. Öztürk, O. Imecik (Konya, Turkey)
| |
Trace elements and minerals in pleural effusions caused by asbestosis mesothelioma and benign conditions
A. V. Basanets, N. S. Opanasenko, I. N. Andrusichyna (Kiev, Ukraine)
| |
Management of malignant pleural effusion
G. Sarikos, S. Baka, A. Kortsaris, G. Galaktidou, Z. Iakovidou (Thessaloniki, Greece)
| |
Vascular endothelial growth factor (VEGF) in malignant and tuberculous pleural effusions
R. Jankowska, I. Porebska, T. Dyla, W. Szeliga (Wroclaw, Poland)
| |
Prognostic indexes for the efficacy of intrapleural instillation of bleomycin, alpha2-interferon and gamma-interferon in the control of malignant pleural effusions
M. Ferdoutsis, G. Meletis, G. Patsourakis, N. Bachlitzanakis, E. Vakouti, M. Christodoulou, G. Pitsidianakis, G. Gavriilidis, D. Bouros (Heraklion, Greece)
| |
Granular cell tumours of the tracheobronchial tree
J. van der Maten, J. L. G. Blaauwgeers, A. J. M. Schreurs, S. S. Wagenaar, T. G. Sutedja (Amsterdam, The Netherlands)
| |
Lung metastasis of thyroid carcinoma: misunderstanding of existing pathology
S. M. Cherenko, A. S. Larin, M. B. Gorobeyko (Kiev, Ukraine)
| |
Malignant fibrous histiocytoma evolving from multiple lung fibroxanthomas
M. Vašáková, V. Bártù, P. Zatloukal, Z. Kinkor (Prague, Czech Republic)
| |
Paraganglioma of the mediastinum: 10 years' experience
D. M. Jovanovic, N. Z. Pajic, A. Z. Zdravkovic, T. L. Adzic, N. V. Vasic (Belgrade, Yugoslavia)
| |
Inflammatory pseudotumour with Hodgkin-like growth pattern: a case report
A. Ammon, C. Loddenkemper, D. Kaiser, A. Fisseler-Eckhoff (Berlin, Germany)
| |
Endobronchial primary pulmonary non-Hodgkin lymphoma development in a patient with rheumatoid arthritis
S. M. Alpar, A. S. Turgut, H. Lakadamyali, F. Demýrag, B. Kurt (Ankara, Turkey)
| |